Synthesis and cytotoxicity against human cancer cells of novel diazenecarboxamides

Arkivoc

Volumn 2001, Issue 5, 2001, Pages 42-50

  Pieters, Luc ^a   Košmrlj, Janez ^b   Lenaršič, Roman ^b   Kočevar, Marijan ^b   Polanc, Slovenko ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cytotoxic activity; Diazenecarboxamides; Synthesis

Indexed keywords

1 (2 PICOLYL) 2 PHENYLDIAZENEDICARBOXAMIDE; AMIDE; ANTINEOPLASTIC AGENT; ETHYL(4 FLUOROPHENYL)AMINOCARBONYLDIAZENECARBOXYLATE; ETHYL(4 NITROPHENYL)AMINOCARBONYLDIAZENECARBOXYLATE; ETHYL(4 TOLYL)AMINOCARBONYLDIAZENECARBOXYLATE; ISOBUTYLPHENYLAMINOCARBONYLDIAZENECARBOXYLATE; N CYCLOHEXYL 2 (3 CHLOROPYRIDAZIN 6 YL)DIAZENECARBOXAMIDE; N PHENYL 2 (1,3 DIMETHYL 4 NITROPYRAZOL 5 YL)DIAZENECARBOXAMIDE; N PHENYL 2 (2 NITROPHENYL)DIAZENECARBOXAMIDE; N PHENYL 2 (IMIDAZO[1,2 B]PYRIDAZIN 6 YL)DIAZENECARBOXAMIDE; N PHENYL 2 (PENTAFLUOROPHENYL)DIAZENECARBOXAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

EID: 3242691709     PISSN: 14246376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kosower, N. S.; Kosower, E. M. In Glutathione: Chemical, Biochemical, and Medical Aspects; Dolphin, D.; Poulson, R.; Avramović, O., Eds.; Wiley-Interscience: New York, 1989; Part B, pp 319.
2. Košmrlj, J.; Kočevar, M.; Polanc, S. J. Chem. Soc., Perkin Trans. 1 1998, 3917.
3. Osmak, M.; Bordukalo, T.; Košmrlj, J.; Kvajo, M.; Marijanović, Z.; Eljuga, D.; Polanc, S. Neoplasma 1999, 46, 201.
4. Osmak, M.; Bordukalo, T.; Jernej, B.; Košmrlj, J.; Polanc, S. Anti-Cancer Drugs 1999, 10, 853.
5. (a) Kočevar, M.; Mihorko, P.; Polanc, S. Synlett 1995, 241.
6. (b) Kočevar, M.; Mihorko, P.; Polanc, S. J. Org. Chem. 1995, 60, 1466.
7. (c) Košmrlj, J.; Kočevar, M.; Polanc, S. Synlett 1996, 652.
8. (d) Štefane, B.; Kočevar, M.; Polanc, S. J. Org. Chem. 1997, 62, 7165.
9. (e) Trebše, P.; Polanc, S.; Kočevar, M.; Šolmajer, T.; Golič-Grdadolnik, S. Tetrahedron 1997, 53, 1383.
10. (f) Kepe, V.; Požgan, F.; Golobič, A.; Polanc, S.; Kočevar, M. J. Chem. Soc., Perkin Trans. 1 1998, 2813.
11. (g) Vraničar, L.; Polanc, S.; Kočevar, M. Tetrahedron 1999, 55, 271.
12. (h) Štefane, B.; Kočevar, M.; Polanc, S. Tetrahedron Lett. 1999, 40, 4429.
13. (i) Kafka, S.; Trebše, P.; Polanc, S.; Kočevar, M. Synlett 2000, 254.
14. Knight, G. T.; Loadman, M. J. R.; Saville, B.; Wildgoose, J. J. Chem. Soc., Chem. Commun. 1974, 193.
15. Lenaršič, R.; Kočevar, M.; Polanc, S. J. Org. Chem. 1999, 64, 2558.
16. Boyd, M. R.; Paull, K. D. Drug Dev. Res. 1995, 34, 91.